Company news

Botanix Pharmaceuticals Limited news in 2017

Botanix Pharmaceuticals Limited's news releases, calls and decks from 2017, newest first.

View company

Botanix Completes Enrolment of BTX 1503 Acne Patient Study

December 17, 2017

New Antibacterial Results Support BTX 1503 Acne Program

December 4, 2017

Botanix Enrols First Patients in Dermatitis Study

November 22, 2017

Botanix Commences BTX 1204 Dermatitis Patient Study

October 30, 2017

FDA Clears Development Path for BTX 1503

October 8, 2017

Botanix Commences BTX 1503 Acne Patient Study

August 20, 2017

Botanix Completes Successful Phase 1 BTX 1503 Clinical Study

July 3, 2017

12 Month Operational Review Highlights Significant Progress

June 26, 2017

Successful Pilot Study for BTX 1701 Facial Cleanser

June 7, 2017

Completion of Tranche 2 of Capital Raising Placement

May 19, 2017

Botanix Commences First Clinical Study for BTX 1503

May 7, 2017

Completion of the Tranche 1 Placement

April 12, 2017

Reinstatement to official quotation

April 4, 2017

Suspension from Official Quotation

April 3, 2017

Botanix Receives Approval for Synthetic Cannabidiol Trial

March 29, 2017

Export and Import Approvals for Clinical Studies Received

March 23, 2017

Botanix Announces Filing of New Permetrex Product Patents

February 26, 2017

Botanix Announces Expansion of Permetrex License

February 2, 2017

Quarterly Cashflow Report

January 30, 2017

Decks in 2017